3-[3-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-5-yl]-N,N-dimethylpropan-1-amine
C19H21ClN4 — CID 141026666
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[3-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-5-yl]-N,N-dimethylpropan-1-amine
3-[3-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-5-yl]-N,N-dimethylpropan-1-amine (PubChem CID 141026666) has the molecular formula C19H21ClN4 and a molecular weight of 340.86 g/mol. Its IUPAC name is 3-[3-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-5-yl]-N,N-dimethylpropan-1-amine.
Molecular Properties
| Compound Name | 3-[3-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-5-yl]-N,N-dimethylpropan-1-amine |
|---|---|
| PubChem CID | 141026666 |
| Molecular Formula | C19H21ClN4 |
| Molecular Weight | 340.86 g/mol |
| Exact Mass | 340.15 |
| IUPAC Name | 3-[3-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-5-yl]-N,N-dimethylpropan-1-amine |
| SMILES | CN(C)CCCc1[nH]nc(-c2ccc(Cl)cc2)c1-c1ccncc1 |
| InChI | InChI=1S/C19H21ClN4/c1-24(2)13-3-4-17-18(14-9-11-21-12-10-14)19(23-22-17)15-5-7-16(20)8-6-15/h5-12H,3-4,13H2,1-2H3,(H,22,23) |
| InChIKey | CGYUVMIRWOWNNM-UHFFFAOYSA-N |
| XLogP | 4.29 |
| TPSA | 44.81 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 340.86 |
| LogP ≤ 5 | 4.29 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141026666 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.